Success Stories: NIW Approval Received for a Staff Scientist in Chemistry from Antigua and Barbuda with Immense Publications (35) and Citations (5,347)
Client’s Testimonial:
“This is great news, and it happened much more quickly than I'd anticipated.”
On November 18th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Staff Scientist in the Field of Chemistry (Approval Notice).
General Field: Chemistry
Position at the Time of Case Filing: Staff Scientist
Country of Origin: Antigua and Barbuda
State of Residence at the Time of Filing: Texas
Approval Notice Date: November 18th, 2021
Processing Time: 8 months, 9 days
Case Summary:
“[The client’s] research is a major step forward by providing a robust solution for this issue. His work benefits the world’s interest in both saved costs and quality of life by directly contributing to improved recovery outcomes for patients with such injuries.”
“[The client] has improved upon both the public health of the United States and the nation's status as an innovator in medical advances. The overall public health benefits offered by [the client] investigations are immense, considering that his solution bypasses severe side effects such as major infections and the risk of cancer associated with other forms of autoimmune disease treatment. [The client] is thereby a critical resource in both medical practice and scholarly research for the United States.”
These are words of appreciation written for a staff scientist in chemistry from Antigua and Barbuda who came to us in March 2021 seeking help to file his NIW (National Interest Waiver) petition. Our team having ascertained that his case was indeed of value started working on the case and collected the following:
- Updated CVs
- Transcripts from University and Colleges
- Certificates both academic and professional
- Letters of recommendation from experts
- Funding information and peer review service
- Publication and citation history.
- That as an expert in the field he wants to continue developing novel organic chemical substances using synthetic organic chemistry, cheminformatics, and nanoscience to facilitate drug discovery for conditions such as cancer and radiation exposure.
- Evidence of his major funding sources from the National Institutes of Health (NIH), U.S. Department of Defense (DoD), U.S. Army Telemedicine & Advanced Technology Research Center (TATRC), Air Force Research Laboratory Multidisciplinary Research Program of the University Research Initiative (MURI), U.S. Army Medical Research and Materiel Command (USAMRMC), etc.
- That he had published 35 scientific articles which had been cited 5,347 times in the past showing how valuable his work was for his peers around the world.
- That he had also conducted at least one review in the past for a scientific journal in his field.

